DEMENTIA DISCOVERY FUND
DEAD

Serial Number

79207107

Owner

SV Life Sciences Managers LLP

Filing Date

Jul 14, 2016

Add to watchlist:

No watchlists yet
View on USPTO

DEMENTIA DISCOVERY FUND Trademark

Serial Number: 79207107

DEMENTIA DISCOVERY FUND is a trademark filed by SV Life Sciences Managers LLP on July 14, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

SV Life Sciences Managers LLP

71 Kingsway

Entity Type: 99

SV Health Managers LLP (3 trademarks)

71 Kingsway
London WC2B6ST , GB

Entity Type: 99

Trademark Details

Filing Date

July 14, 2016

Registration Date

Not Registered

Goods & Services

Pharmaceutical and medical preparations and substances for the prevention and treatment of dementia; sanitary preparations for medical purposes; pharmaceutical preparations, all for use in the treatment or prevention of brain diseases and degenerative dementia disorders; antiseptic preparations; prescription pharmaceuticals for humans for the prevention and treatment of dementia; veterinary and sanitary products, namely, antibiotics; dietary food supplements; health food supplements; vitamins; dietetic substances adapted for medical use, namely, sugar substitutes; food for babies; foods for medical purposes, namely, food for enteral feeding for teens adults and elders; homeopathic pharmaceuticals for use in the treatment of dementia; medicinal drinks; anti-diabetic drugs; hypertension medications; steroid hormones; non-steroidal anti-inflammatory drugs; chemicals in the nature of medical diagnostic reagents for use in medical and veterinary diagnosis of dementia disorders

Insurance, namely, insurance brokerage; financial affairs, namely, financial information, management and analysis services; monetary affairs, namely, monetary exchange and monetary strategic consultation and research; real estate affairs, namely, leasing of real estate, real estate brokerage and real estate appraisal services; financing services in relation to medical research; humanitarian aid and development, namely, charitable fundraising and financial support services for research in dementia; charitable fundraising for dementia research; charitable fundraising for the purchase of food, clothing and medical items for those in need; financial sponsorship of medical research in the field of dementia; financial management and administration of charitable funds for dementia research; distribution and allocation of charitable funds, namely, accepting and administering monetary charitable contributions to fund medical research; credit card and charge card payment processing services; providing of financial information regarding corporate donations and payroll donations by employees; financial information, advisory, and consultancy services in relation to the aforesaid services

Medical services; the provision of medical information, online via the Internet, on the subject of all aspects of dementia diseases and the prevention of all types dementia diseases; medical services relating to the science of nutrition and the use of medical and pharmaceutical preparations and substances; medical services in relation to the recommendation and prescribing of medicaments and medical products of all kinds; medical services concerning dementia, namely physician, nursing, midwifery and hospital services; diagnostic and laboratory services, namely, medical testing for diagnostic or treatment purposes; hygienic and beauty care for human beings; agricultural services, namely, agricultural advice; dentistry services; medical analysis for the diagnosis and treatment of individuals and groups of people with dementia including x-ray examinations and taking blood samples; pharmaceutical advice; medical clinic services; medical treatment services; medical analysis services; medical information services; nursing services; information, advisory and consultancy services relating to all the aforesaid, including information provided on-line from a computer database, intranets, extranets and the Internet

Scientific and technological services, namely, research and design in the field of pharmaceutical development; scientific and technological services, namely, medical research and product development in the field of dementia; industrial analysis and research services in the field of computer hardware; design and development of computer hardware and software; design and development of computer hardware and software connected with dementia; Laboratory analysis in the field of pharmaceuticals and clinical trials in the pharmaceutical, biotechnology and medical device fields; laboratory research in the field of pharmaceuticals and clinical trials in the pharmaceutical, biotechnology and medical device fields; laboratory testing services in the field of pharmaceutical product testing; medical research laboratory services; medical research services in relation to the causes, symptoms, diagnosis, treatment and prevention of dementia; scientific genetic research in the field of dementia; provision of scientific research facilities in the nature of laboratories; medical research in relation to medicines and pharmaceuticals; medical research services; design and development of mobile device software applications; design and development of computer programs

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Dec 2, 2022 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 11, 2021 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jun 23, 2021 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 23, 2021 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Jun 18, 2021 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jul 9, 2020 NREP
ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Jun 23, 2020 MAB3
ABANDONMENT - AFTER EX PARTE APPEAL
Jun 23, 2020 ABN3
EXPARTE APPEAL TERMINATED
Jun 23, 2020 EXPT
EX PARTE APPEAL-REFUSAL AFFIRMED
Apr 1, 2020 EXPA
NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Nov 20, 2019 GNSN
EXAMINERS STATEMENT E-MAILED
Nov 20, 2019 GNES
EXAMINERS STATEMENT - COMPLETED
Nov 20, 2019 CNES
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Sep 30, 2019 JURT
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Jul 26, 2019 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Jul 26, 2019 GECD
ACTION CONTINUING FINAL - COMPLETED
Jul 26, 2019 CNCF
EX PARTE APPEAL-INSTITUTED
Jun 25, 2019 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jun 25, 2019 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jun 20, 2019 EXAF
NOTICE OF REVIVAL - E-MAILED
Jun 19, 2019 NREV
PETITION GRANTED - TTAB APPEAL FILED
Jun 19, 2019 PGTT
ASSIGNED TO PETITION STAFF
Jun 19, 2019 APET
EXPARTE APPEAL RECEIVED AT TTAB
May 23, 2019 EXAF
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 21, 2019 TROA
TEAS PETITION TO REVIVE RECEIVED
May 21, 2019 PROA
EXPARTE APPEAL RECEIVED AT TTAB
May 21, 2019 EXAF
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 21, 2019 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 21, 2019 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 21, 2019 ABN2
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 2, 2018 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 17, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 17, 2018 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Oct 11, 2018 NREP
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 5, 2018 GNFN
FINAL REFUSAL E-MAILED
Sep 5, 2018 GNFR
FINAL REFUSAL WRITTEN
Sep 5, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 3, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 2, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 2, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 2, 2018 GNRN
NON-FINAL ACTION E-MAILED
Feb 2, 2018 GNRT
NON-FINAL ACTION WRITTEN
Feb 2, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 11, 2017 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 11, 2017 TCCA
REFUSAL PROCESSED BY IB
Jul 1, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 9, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jun 9, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 29, 2017 RFCR
NON-FINAL ACTION WRITTEN
May 28, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
May 17, 2017 MAFR
ASSIGNED TO EXAMINER
May 13, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 13, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 11, 2017 REPR